CURAVIDA PHARMA LIMITED
Significant control: Peter Mollison (25–50%), Ka Yan Che (25–50%) and 1 more
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Curavida Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Curavida Pharma Limited sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
CURAVIDA PHARMA LIMITED is an active private limited company (company number 15174256) incorporated on 29 September 2023, registered in London. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest micro accounts cover the period ending 30 September 2025, showing net assets of −£9,670, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 322433% on the prior period (£3).
By net assets it sits in the bottom quarter of 143 comparable companies in London (median £100, upper quartile £10k).
Ownership and control
- Mr Peter Mollison
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Ka Yan Che
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Haziq Patel
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 29 September 20233 yrs ago
- Next accounts due
- 30 June 2027in 246 days
- Confirmation statement due
- 13 October 2027in 351 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 21200
- Manufacture of pharmaceutical preparations
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | −£9,670 | — | — | £20k | — | — | 0 |
| 30 September 2024 | £3 | — | — | £0 | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets below zeroNet assets £-9,670 at 30 September 2025
- Net assets down 25% or more on the prior period-322433.3% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.55
- Incorporated two to five years agoIncorporated 29 September 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 351 days
- Next accounts duein 246 days
- Accounts period endNet liabilities £9,670 · micro accounts
- Accounts period endNet assets £3 · micro accounts
- Incorporated
Similar companies in London
- FORM PHARMACEUTICALS LIMITEDLondon · inc. Oct 2023
- VERANYO LTDLondon · inc. Aug 2023
- ROGIDA MEDICAL LTDLondon · inc. Aug 2023
- POUT LONDON LIMITEDLondon · inc. Dec 2023
- PHARMAGEN HESSEN PGH LTDLondon · inc. Dec 2023
- SURROUND THERAPEUTICS LTDLondon · inc. Jun 2023
All companies incorporated on 29 September 2023 · in Sept 2023.
Reminders for CURAVIDA PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.